Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LAPTM4B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
FITM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ETNPPL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CBR3-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
TMPO - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CTNNAL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMCO3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CALCR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANXA5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIAA2013 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM176B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZXDC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC35F3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RTKN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF674-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SHMT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDCA7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928195 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC35B4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on